AbbVie Inc. is 36.8x more valuable than BIOMARIN PHARMACEUTICAL INC by market capitalization ($399.47 B vs $10.86 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | BMRN | ABBV |
|---|---|---|
| Market cap | $10.86 B | $399.47 B |
| US-listed rank | #899 | #28 |
| Revenue (latest FY) | $3.22B | $61.16B |
| Net income (latest FY) | $348.90M | $4.23B |
| Net margin | 10.8% | 6.9% |
| P/E (trailing FY) | 31.1 | 94.5 |
| SEC filings | 2,709 | 1,008 |
AbbVie Inc. is 36.8x more valuable than BIOMARIN PHARMACEUTICAL INC by market capitalization ($399.47 B vs $10.86 B).
In their latest fiscal years, BIOMARIN PHARMACEUTICAL INC reported $3.22B in revenue while AbbVie Inc. reported $61.16B.
Full pages: BIOMARIN PHARMACEUTICAL INC and AbbVie Inc., or browse the full rankings.